Inovio Pharma (INO) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 --0%
EPS Growth %: +36.1%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +36.1%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $116.67 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
- Schwab's May activity shows margin loans nearly double
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
